|Articles|February 1, 2006

Psychiatric Issues in Emergency Care Settings

Psychiatric Issues in Emergency Care Settings Vol 5 No 1
Volume 5
Issue 1

Evaluating for Alcohol and Substance AbuseAlcohol and Drug Abuse Intervention in the Emergency Department: A Step Toward RecoverySubstance Use Disorders in the Emergency SettingDual Diagnosis: A Challenge for ED Clinicians

Editorial

LESLIE S. ZUN, MD, MBA

Patient Assessment

MARCELLO A. MAVIGLIA, MD, MPH

Clinical Case Presentations

MARCELLO A. MAVIGLIA, MD, MPH

Commentary

PETER F. BUCKLEY, MD

also inside: Literature Highlights, Reader Forum, Meeting Calendar

Articles in this issue

almost 20 years ago

Article

Back Issues Available

almost 20 years ago

Article

Psychiatric Price of Steroid Abuse

almost 20 years ago

Article

ADD THE BLACK BOX TO MORE LABELS?

almost 20 years ago

Article

PSYCHIATRIC SYMPTOMS SIGNAL AUTOIMMUNE DISORDERS

almost 20 years ago

Article

DECADE OF DISCOVERY IN PEDIATRIC BD

almost 20 years ago

Article

Evaluating for Alcohol and Substance Abuse

almost 20 years ago

Article

Can you give our staff some guidance on the appropriate use of critical incident stress debriefing and psychological first aid?

almost 20 years ago

Article

Are benzodiazepines appropriate to prescribe for survivors and others after an incidence of mass trauma?

almost 20 years ago

Article

Dual Diagnosis: A Challenge for ED Clinicians

almost 20 years ago

Article

Substance Use Disorders in the Emergency Setting

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Latest CME

Video

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Evaluating for Alcohol and Substance AbuseAlcohol and Drug Abuse Intervention in the Emergency Department: A Step Toward RecoverySubstance Use Disorders in the Emergency SettingDual Diagnosis: A Challenge for ED Clinicians

Articles in this issue

Newsletter

Related Content

AD04 for Alcohol Use Disorder: Favorable Feedback From FDA Following End of Phase 2 Meeting

FDA Grants Fast Track Designation to Pemvidutide for Treatment of Alcohol Use Disorder

End of Phase 2 Meeting With the FDA: Adial Prepares to Advance AD04 for Alcohol Use Disorder

Differences in Experiences Must Influence Interventions

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Latest CME

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

In Memoriam: 2 Terrible Ironies of Being a Psychiatrist

Everything You Need to Know About the Approval of Lumateperone for Major Depressive Disorder

Lamotrigine: An Update on Its Role in Bipolar Disorder

Post-Hoc Analysis of Predictive Factors for Response to Adjunctive Cobenfy

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD